vTv Therapeutics VTVT
NASDAQ VTVT
$33.35 -0.12 (-0.36%)
At close: Sep 4, 2026 · 4:00 PM EDT

vTv Therapeutics (VTVT) Accumulated Expenses (2014 - 2015)

vTv Therapeutics' (VTVT) quarterly Accumulated Expenses came in at $1.0 million in Q4 2015, up 11455.56% year-over-year from N/an in Q4 2014, and up 11455.56% quarter-over-quarter from $9000.0 in Q4 2014.

Analysis

vTv Therapeutics (VTVT) Accumulated Expenses (2014 - 2015) Analysis & Trends

vTv Therapeutics has disclosed Accumulated Expenses across 2 years of filings, most recently posting $1.0 million for Q4 2015.

  • In Q4 2015, Accumulated Expenses rose 11455.56% year-over-year to $1.0 million; the TTM figure through Dec 2015 stood at $1.0 million (up 11455.56% YoY), while the FY2015 annual figure was $1.0 million, up 11455.56% from the prior year.
  • Accumulated Expenses came in at $1.0 million for Q4 2015 at vTv Therapeutics, up from $9000.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $1.0 million in Q4 2015 to a low of $9000.0 in Q4 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn
7 Revolution Medicines 45.00 Bn 45.00 Bn -
8 BeOne Medicines 40.49 Bn 35.39 Bn 1.53 Bn
9 Incyte 25.47 Bn 20.94 Bn 1.57 Bn
10 vTv Therapeutics 413.85 Mn 413.85 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 1.04 Mn
Dec 31, 2014 9,000.00